VITILIGO
RESEARCH STUDY

Vitiligo occurs when pigment-producing cells die. The loss of skin color can affect any part of the body. Treatment may improve the appearance of the skin. Researchers are focused on trying to find ways to treat this condition.

Our Study

A research study is now underway in Columbus to evaluate an investigational oral medication that may treat vitiligo.

Participants Receive:

Study-related medical care at no cost
Investigational medication from a local physician at no cost
Compensation for time and travel may be provided

To see if you qualify, contact Remington-Davis Clinical Research by completing the form.

To contact the study coordinator, please enter your contact information below:

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid mobile number.

Please enter valid zip code.

Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.

VITILIGORESEARCH STUDY

Our Study

Participants Receive:

To see if you qualify, contact Remington-Davis Clinical Research by completing the form.

VITILIGO
RESEARCH STUDY